Show simple item record

dc.contributor.authorBerntorp, E
dc.contributor.authorÅgren, A
dc.contributor.authorAledort, L
dc.contributor.authorBlombäck, M
dc.contributor.authorCnossen, M H
dc.contributor.authorCroteau, S E
dc.contributor.authorvon Depka, M
dc.contributor.authorFederici, A B
dc.contributor.authorGoodeve, A
dc.contributor.authorGoudemand, J
dc.contributor.authorMannucci, P M
dc.contributor.authorMourik, M
dc.contributor.authorÖnundarson, P T
dc.contributor.authorRodeghiero, F
dc.contributor.authorSzántó, T
dc.contributor.authorWindyga, J
dc.date.accessioned2018-06-11T11:04:58Z
dc.date.available2018-06-11T11:04:58Z
dc.date.issued2018-05
dc.date.submitted2018
dc.identifier.citationFifth Åland Island conference on von Willebrand disease. 2018, 24 Suppl 4:5-19 Haemophiliaen
dc.identifier.issn1365-2516
dc.identifier.pmid29687935
dc.identifier.doi10.1111/hae.13475
dc.identifier.urihttp://hdl.handle.net/2336/620587
dc.descriptionTo access publisher's full text version of this article click on the hyperlink belowen
dc.description.abstractThe fifth Åland Island meeting on von Willebrand disease (VWD) was held on the Åland Islands, Finland, from 22 to 24 September 2016-90 years after the first case of VWD was diagnosed in a patient from the Åland Islands in 1926. This meeting brought together experts in the field of VWD to share knowledge and expertise on current trends and challenges in VWD. Topics included the storage and release of von Willebrand factor (VWF), epidemiology and diagnostics in VWD, treatment of VWD, angiogenesis and VWF inhibitors.
dc.description.sponsorshipOctapharmaen
dc.language.isoenen
dc.publisherWileyen
dc.relation.urlhttps://onlinelibrary.wiley.com/doi/epdf/10.1111/hae.13475en
dc.rightsArchived with thanks to Haemophilia : the official journal of the World Federation of Hemophiliaen
dc.subjectBlóðsjúkdómaren
dc.subjectDreyrasýkien
dc.subjectArfgengien
dc.subjectHEM12en
dc.subject.meshvon Willebrand Diseasesen
dc.subject.meshHemorrhagic Disordersen
dc.subject.meshGeneticsen
dc.titleFifth Åland Island conference on von Willebrand disease.en
dc.typeArticleen
dc.contributor.department[ 1 ] Lund Univ, Skane Univ Hosp, Ctr Thrombosis & Haemostasis, Malmo, Sweden Show more [ 2 ] Karolinska Univ Hosp, Coagulat Unit, Dept Med, Div Haematol, Stockholm, Sweden Show more [ 3 ] Mt Sinai Hosp, Dept Hematol & Med Oncol, New York, NY 10029 USA Show more [ 4 ] Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden Show more [ 5 ] Erasmus Univ, Med Ctr, Sophia Childrens Hosp Rotterdam, Rotterdam, Netherlands Show more [ 6 ] Harvard Med Sch, Boston Childrens Hosp, Boston Hemophilia Ctr, Boston, MA USA [ 7 ] Werlhof Inst Hannover, Hannover, Germany Show more [ 8 ] Univ Milan, L Sacco Univ Hosp, Dept Oncol & Oncol Hematol, Haematol & Transfus Med, Milan, Italy Show more [ 9 ] Univ Sheffield, Haemostasis Res Grp, Sheffield, S Yorkshire, England [ 10 ] Sheffield Childrens NHS Fdn Trust, Sheffield Diagnost Genet Serv, Sheffield, S Yorkshire, England Show more [ 11 ] Lille Univ Hosp, Dept Haematol, Lille, France [ 12 ] IRCCS Ca Grande Maggiore Policlin Hosp Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy Show more [ 13 ] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands Show more [ 14 ] Univ Iceland, Landspitali Univ Hosp, Sch Med, Reykjavik, Iceland Show more [ 15 ] San Bortolo Hosp, Dept Cell Therapy & Hematol, Vicenza, Italy Show more [ 16 ] Univ Helsinki, Coagulat Disorders Unit, Cent Hosp, Dept Hematol,HUSLAB Lab Serv, Helsinki, Finland Show more [ 17 ] Univ Helsinki, Coagulat Disorders Unit, Cent Hosp, Dept Clin Chem,HUSLAB Lab Serv, Helsinki, Finland [ 18 ] Inst Hematol & Transfus Med, Dept Disorders Hemostasis & Internal Med, Warsaw, Polanden
dc.identifier.journalHaemophilia : the official journal of the World Federation of Hemophiliaen
dc.rights.accessOpen Access - Opinn aðganguren
dc.departmentcodeHEM12
html.description.abstractThe fifth Åland Island meeting on von Willebrand disease (VWD) was held on the Åland Islands, Finland, from 22 to 24 September 2016-90 years after the first case of VWD was diagnosed in a patient from the Åland Islands in 1926. This meeting brought together experts in the field of VWD to share knowledge and expertise on current trends and challenges in VWD. Topics included the storage and release of von Willebrand factor (VWF), epidemiology and diagnostics in VWD, treatment of VWD, angiogenesis and VWF inhibitors.


This item appears in the following Collection(s)

Show simple item record